ScholarLens Back to search
2008•Journal of Travel MedicineOpen access

Yellow Fever–Associated Viscerotropic Disease in Barcelona, Spain

José Muñóz, Anna Vilella, Cristina Domingo, Josep M. Nicolás, Fernando de Ory, M Corachán, Antônio Tenório, Joaquím Gascón

Open full text 31 citations

Abstract

Yellow fever vaccine is a live, attenuated viral preparation from the 17D virus strain. Since 1996, 34 cases of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) have been described. We report a new case of YEL-AVD. Given the potential risks associated with the vaccine, physicians should consider vaccination only for patients truly at risk for exposure to yellow fever, especially for primovaccination.

Open-access reader

About this research paper

What this paper is about

Yellow fever vaccine is a live, attenuated viral preparation from the 17D virus strain. Since 1996, 34 cases of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) have been described. We report a new case of YEL-AVD. Given the potential risks associated with the vaccine, physicians should consider vaccination only for patients truly at risk for exposure to yellow fever, especially for primovaccination.

Why it matters

OpenAlex reports 31 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Yellow fever vaccine is a live, attenuated viral preparation from the 17D virus strain. Since 1996, 34 cases of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) have been described. We report a new case of YEL-AVD. Given the potential risks associated with the vaccine, physicians should consider vaccination only for patients truly at risk for exposure to yellow fever, especially for primovaccination.

Key concepts: Yellow fever vaccine, Medicine, Yellow fever, Vaccination, Virology, Disease, Virus, Immunology

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Yellow Fever–Associated Viscerotropic Disease in Barcelona, Spain — Research Paper | ScholarLens